Results 191 to 200 of about 146,080 (258)

Long‐Term Outcomes of Prepubertal‐Onset Vulvar Lichen Sclerosus

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Background Vulvar lichen sclerosus (VLS) is a chronic inflammatory dermatosis affecting the vulvar and perianal skin. VLS has a bimodal age of onset, in pre‐pubertal and post‐menopausal age groups. Long‐term outcomes of pre‐pubertal VLS are unclear.
Alexandra Savage   +5 more
wiley   +1 more source

Reviewing the benefits and clinical outcomes of oral fibroblasts over mesenchymal stem cells for repairing periodontal defects during or after orthodontic tooth movement

open access: yesPeriodontology 2000, EarlyView.
Abstract Orthodontic therapy applies forces to teeth, causing an inflammatory reaction in the periodontal ligament. This is repaired by remodeling of the periodontium, allowing tooth displacement. Although orthodontic therapy is mostly initiated during childhood and adolescence, the number of adults seeking this treatment is increasing as our society's
Ludovica Parisi   +4 more
wiley   +1 more source

30 years of enamel matrix derivative: Mimicking tooth development as a clinical concept

open access: yesPeriodontology 2000, EarlyView.
Abstract The use of growth factors (GFs) has become a cornerstone of modern regenerative periodontology. While the extent to which GFs enhance tissue regeneration compared to other biomaterials was initially uncertain, it is now well established that GFs play a critical role in the regeneration of various tissue types.
Richard J. Miron   +7 more
wiley   +1 more source

Long‐term clinical outcomes of periodontal regeneration of intrabony defects: A systematic review and meta‐analysis

open access: yesPeriodontology 2000, EarlyView.
Abstract This systematic review and meta‐analysis aimed to evaluate the long‐term clinical outcomes of regenerative procedures compared with access flap surgery for the treatment of intrabony defects, with a minimum follow‐up period of 5 years. A systematic review protocol following PRISMA guidelines was conducted.
Hom‐Lay Wang   +4 more
wiley   +1 more source

The Anti-SLAMF7 Antibody, Elotuzumab, Induces Antibody-Dependent Cellular Cytotoxicity Against CLL Cell Lines. [PDF]

open access: yesMolecules
Kľoc D   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy